U.S., Jan. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07313475) titled 'Evaluation of the Cryocheck HexLA Integrated TCA for the Detection of Lupus Anticoagulant' on Dec. 17, 2025.
Brief Summary: Lupus anticoagulant (LA) testing is performed using two screening tests: activated partial thromboplastin time (APTT) and diluted Russell's viper venom time. If one of the screening tests is positive, a confirmation test based on the same principle is performed.
The HUS Hematology Laboratory uses an integrated APTT for LA testing, consisting of a screening reagent: Cephen LS, and a confirmation reagent: Cephen (Hyphen Biomed).
The aim of this study is to determine whether another integrated activated partial t...